Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMPL004-6599 in healthy male volunteers
NCT03597971Phase 1Terminated
- Sponsor
- Nutrition Science Partners Limited
- Start
- Mar 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of andrographolide in ulcerative colitis (UC) and Crohn's disease (4 arms), sponsored by Nutrition Science Partners Limited. Primary endpoints: Incidence of Treatment-Emergent Adverse Events and Incidence of Participants with Abnormal Laboratory Values. Started Mar 2018; status: terminated.
02
Drugs
andrographolide
03
Conditions
ulcerative colitis (UC)Crohn's disease
Beyond the preview
Go deeper on NCT03597971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03597971.